Brief: HCW Biologics Granted Second Fundamental Patent
07/12/2022 12:51
Dec 7 (Reuters) - HCW Biologics Inc HCWB.O :
* HCW BIOLOGICS IS GRANTED SECOND FUNDAMENTAL PATENT: U.S.
PATENT
FOR MULTI-CHAIN CHIMERIC POLYPEPTIDE CREATED WITH TOBI™ PLATFORM
Source text for Eikon: ID:nGNX9WTsc7
Further company coverage: HCWB.O
Recent news on Hcw Biologics
See all newsBrief: HCW Biologics Proposed Resale Of Up To 5.69 Million Shares Of Common Stock
Brief: HCW Biologics To Regain Full Rights For Two Commercial-Ready Reagents From Wugen
Brief: HCW Biologics Prices Private Placement Of 2.8 Mln Units At $1.405 Per Unit
NASDAQ RESUMED AT 09:59 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:54 AM